Saturday, 15 December 2018

Kirin, Mitsui to acquire stake in supplement firm

10 July 2018 | News

The two Japanese companies will own 40 percent each of New York-based Thorne through the investment expected to total over ¥5 billion each.

Image credit- crmgiant.eu

Image credit- crmgiant.eu

Beverage group Kirin Holdings Co. and trading house Mitsui & Co. are planning to jointly acquire an 80 percent stake in Thorne Research Inc., a U.S. developer and supplier of high-quality health supplements.

The two Japanese companies will own 40 percent each of New York-based Thorne through the investment expected to total over ¥5 billion each.

The move by Kirin is part of its efforts to strengthen health business. It has been working to develop the Lactococcus lactis strain Plasma, which is said to boost the body’s immunity.

Kirin plans to sell supplement materials in North America through cooperation with Mitsui, which operates hospitals and pharmacies overseas.

Thorne sells its products primarily through medical professionals. It is considering providing personalized nutrition service in Japan and other parts of Asia.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Is urbanization dictating future nutrition solutions in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls